DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis
NCT02239458
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
Saxagliptin
Sponsor
Ram Weiss